Toshiba moves to new Sun platform to boost nuclear workstation’s power
Company will also display E.Cam from SiemensAt its Society of Nuclear Medicine booth, Toshiba America Medical Systems, of Tustin, CA, plans to highlight the processing speed of the latest version of its nuclear medicine workstation. Toshiba's
Company will also display E.Cam from Siemens
At its Society of Nuclear Medicine booth, Toshiba America Medical Systems, of Tustin, CA, plans to highlight the processing speed of the latest version of its nuclear medicine workstation. Toshiba's computer is running on an Ultra 1 170, which is based on a speedy UltraSPARC CPU developed by Sun Microsystems of Mountain View, CA.
Toshiba decided to switch to the Sun platform in 1992 and follow the computer developer as it brings faster new workstations to market, according to Steve Sickels, acting director of Toshiba's nuclear medicine business unit. Since then, Toshiba has developed its software to make the transfer to each new Sun platform as seamless as possible.
"It's nice to take software off an old Sun computer, put it on a brand-new one, and see it work three or four times faster," Sickels said. "We don't have to wait a long time to reconfigure and reprogram software to make it run on new Sun systems."
Toshiba has made its workstation technology a major point of differentiation between itself and its nuclear medicine competitors. That's readily apparent in the recent agreement Toshiba signed with Siemens to sell that vendor's E.Cam variable-angle dual-head gamma camera (SCAN 4/2/97). Toshiba's version of E.Cam will be sold with Toshiba's Ultra workstation, rather than the Icon computer developed by Siemens.
Toshiba will display an E.Cam gantry in its SNM booth, in addition to other cameras in the company line, like the fixed-angle dual-head GCA 7200A and single-head GCA 7100A, both of which also employ Ultra computers. Toshiba is ready to begin taking orders for E.Cams, and plans to begin shipping them in the fourth quarter. E.Cam enables Toshiba to participate in the cardiac imaging segment of nuclear medicine for the first time, and the company plans to discuss cardiac applications such as quantitative gated SPECT, according to Sickels.
In other areas of its booth, Toshiba will emphasize DICOM connectivity and the ability to use the Internet to transfer images with Toshiba's Infinia personal computer. Another Toshiba technology, digital video disk (DVD) will be displayed as a possible high-density storage medium for nuclear medicine images. Toshiba is still 12 to 18 months away from selling DVD to the clinical market, as the company is still working on rewritable DVD technology, Sickels said.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
